EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer

Shih-Hong Khoo, Pei-Ru Wu, Kun-Tu Yeh, Shih-Lan Hsu, Chi-Hao Wu

Journal of Food and Drug Analysis · 15.12.2023 · 31 (4)

DOI: 10.38212/2224-6614.3475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 15.12.2023. Verfasst von Shih-Hong Khoo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 110301, Taiwan. Hauptthemen laut MEDLINE: Clinical Relevance, Prostatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dietary factors and chronic hyperglycemia are linked to the formation of advanced glycation end products (AGEs) and prostate cancer (PCa) risk. The activation of the receptor for AGEs (RAGE) acts as a bridge between various RAGE ligands and certain malignancies. This study showed that the interaction of AGEs and RAGE promoted PCa cell proliferation, invasion, and autophagy-mediated survival in response to chemotherapeutic agents. RAGE-overexpressed PCa cells underwent epithelial-mesenchymal transition and showed increased cancer stem cell-like properties. In mouse xenograft models, RAGE-overexpressed cells showed more substantial tumorigenic capacity than parental cells, whereas RAGE knockdown decreased tumorigenicity. The clinical data validated a positive correlation between high AGE and RAGE expressions with poor clinical outcomes. Our findings suggest that the AGE-RAGE axis facilitates PCa progression and aggressiveness. Prostatic AGEs and RAGE expression levels are associated with PCa prognosis. Adherence to a reduced-AGE diet and targeting RAGE are potential approaches to complement and synergize with the current PCa therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical RelevanceProstatic NeoplasmsMaleHumansMiceAnimalsReceptor for Advanced Glycation End ProductsPrognosisDisease Models, Animal

Substanzen

Receptor for Advanced Glycation End Products

Autor:innen und Institutionen

  • School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 110301, Taiwan.
  • Department of Pathology, Cheng-Ching General Hospital, Taichung 40764, Taiwan.
  • Department of Surgical Pathology, Changhua Christian Hospital, Changhua 50006, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung 40227, Taiwan.
  • Department of Medical Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan.

Zitieren

APA

Khoo, S. H., Wu, P. R., Yeh, K. T., Hsu, S. L., & Wu, C. H. (2023). Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer. Journal of Food and Drug Analysis, 31(4). https://doi.org/10.38212/2224-6614.3475

Vancouver

Khoo SH, Wu PR, Yeh KT, Hsu SL, Wu CH. Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer. Journal of Food and Drug Analysis. 2023;31(4). doi:10.38212/2224-6614.3475

BibTeX
@article{Khoo2023,
  author = {Khoo, Shih-Hong and Wu, Pei-Ru and Yeh, Kun-Tu and Hsu, Shih-Lan and Wu, Chi-Hao},
  title = {Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer},
  journal = {Journal of Food and Drug Analysis},
  year = {2023},
  volume = {31},
  number = {4},
  doi = {10.38212/2224-6614.3475}
}
Kostenlos starten →